Brief: Talis Biomedical Eliminates Andrew Lukowiak As President And Chief Scientific Officer
26/01/2024 22:03
Jan 26 (Reuters) - Talis Biomedical Corp TLIS.O :
* TALIS BIOMEDICAL CORP - ANDREW LUKOWIAK'S POSITION AS
PRESIDENT
AND CHIEF SCIENTIFIC OFFICER WAS ELIMINATED AS OF JANUARY 14,
2024
* TALIS BIOMEDICAL CORP - DOES NOT INTEND TO REPLACE
LUKOWIAK'S
POSITION AS PRESIDENT AND CHIEF SCIENTIFIC OFFICER
Source text for Eikon: ID:
Further company coverage: TLIS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Talis Biomedical
See all newsBrief: Talis Biomedical Says Nasdaq Believes Co Is 'Public Shell' And Continued Listing Of Its Common Stock Is No Longer Warranted
Brief: Talis Biomedical Says Accepting Voluntary Resignation Of Heinrich Dreismann From Board Effective August 1
Brief: Talis Biomedical Eliminates Andrew Lukowiak As President And Chief Scientific Officer
Talis Biomedical up on plans to explore strategic options, job cuts
Brief: Talis Biomedical Announces Exploration Of Strategic Alternatives And Cost Reduction Plan To Preserve Cash